Check out this Satellite Symposium organised by the ESWI IDC and supported by IFPMA and Sanofi from ESWI2026.

Read an interview with Marianne Takki, Head of Unit for Disease Prevention and Health Promotion at the European Commission

Cardiovascular complications contribute to adverse outcomes in patients with influenza and SARS-CoV-2 infections. While the association of RSV infection with cardiovascular events (CVE) has been described, data are limited.

What is the risk of acute cardiovascular complications in adults hospitalized for respiratory syncytial virus (RSV) vs influenza or SARS-CoV-2 Omicron infection?

People with noncommunicable diseases (NCDs) are at a higher risk of contracting vaccine-preventable diseases, such as influenza, with a higher likelihood of severity and complications.

In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.

IDC launched a social media campaign to highlight the impact of influenza on people living with diabetes and the crucial importance of influenza vaccine uptake for this risk group.

Is a COVID-19 diagnosis associated with increased incident diagnoses of type 2 diabetes in children and adolescents?